HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 192 filers reported holding HORIZON PHARMA PLC in Q2 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,447,000 | -2.8% | 101,900 | 0.0% | 0.21% | +2.5% |
| Q4 2017 | $1,488,000 | +15.2% | 101,900 | 0.0% | 0.20% | +5.2% |
| Q3 2017 | $1,292,000 | +6.8% | 101,900 | 0.0% | 0.19% | +6.1% |
| Q2 2017 | $1,210,000 | -19.7% | 101,900 | 0.0% | 0.18% | -14.6% |
| Q1 2017 | $1,506,000 | -8.7% | 101,900 | 0.0% | 0.21% | -16.2% |
| Q4 2016 | $1,649,000 | -10.7% | 101,900 | 0.0% | 0.25% | -7.7% |
| Q3 2016 | $1,847,000 | +10.1% | 101,900 | 0.0% | 0.27% | -2.1% |
| Q2 2016 | $1,678,000 | -0.6% | 101,900 | 0.0% | 0.28% | -1.8% |
| Q1 2016 | $1,688,000 | -23.6% | 101,900 | 0.0% | 0.28% | -18.1% |
| Q4 2015 | $2,208,000 | +248.3% | 101,900 | +218.4% | 0.35% | +237.9% |
| Q3 2015 | $634,000 | -43.0% | 32,000 | 0.0% | 0.10% | -34.4% |
| Q2 2015 | $1,112,000 | – | 32,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,959,819 | $96,430,000 | 10.71% |
| Consonance Capital Management LP | 5,793,903 | $93,745,000 | 10.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,956,988 | $144,924,000 | 5.96% |
| JW Asset Management, LLC | 507,075 | $8,205,000 | 5.46% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 6,682,618 | $108,125,000 | 5.23% |
| NEXTHERA CAPITAL LP | 500,000 | $8,090,000 | 4.74% |
| Lion Point Capital, LP | 1,164,414 | $18,840,000 | 4.58% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 4,503,900 | $72,873,000 | 3.52% |
| ARMISTICE CAPITAL, LLC | 650,000 | $10,517,000 | 2.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 8,081,650 | $130,761,000 | 2.48% |